182 related articles for article (PubMed ID: 30221668)
21. Laboratory validation of formal concept analysis of the methylation status of microarray-detected genes in primary breast cancer.
Kassim SK; Shehata HH; Abou-Alhussein MM; Sallam MM; Amin II
Tumour Biol; 2017 Jun; 39(6):1010428317698390. PubMed ID: 28618938
[TBL] [Abstract][Full Text] [Related]
22. Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia.
Li Y; Liu S; Wang H; Mai H; Yuan X; Li C; Chen X; Wen F
PLoS One; 2017; 12(3):e0173472. PubMed ID: 28278270
[TBL] [Abstract][Full Text] [Related]
23. Hypermethylation of selected genes in endometrial carcinogenesis.
Visnovsky J; Fiolka R; Kudela E; Slavik P; Krkoska M; Lasabová Z; Danko J
Neuro Endocrinol Lett; 2013; 34(7):675-80. PubMed ID: 24464006
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer.
Jia N; Wang J; Li Q; Tao X; Chang K; Hua K; Yu Y; Wong KK; Feng W
Oncotarget; 2016 Dec; 7(51):84785-84797. PubMed ID: 27764784
[TBL] [Abstract][Full Text] [Related]
25. Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.
Jones A; Teschendorff AE; Li Q; Hayward JD; Kannan A; Mould T; West J; Zikan M; Cibula D; Fiegl H; Lee SH; Wik E; Hadwin R; Arora R; Lemech C; Turunen H; Pakarinen P; Jacobs IJ; Salvesen HB; Bagchi MK; Bagchi IC; Widschwendter M
PLoS Med; 2013 Nov; 10(11):e1001551. PubMed ID: 24265601
[TBL] [Abstract][Full Text] [Related]
26. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic disturbed flow induces differential DNA methylation of endothelial Kruppel-Like Factor 4 promoter in vitro and in vivo.
Jiang YZ; Jiménez JM; Ou K; McCormick ME; Zhang LD; Davies PF
Circ Res; 2014 Jun; 115(1):32-43. PubMed ID: 24755985
[TBL] [Abstract][Full Text] [Related]
28. Methylation analysis of tumor suppressor genes in endometroid carcinoma of endometrium using MS-MLPA.
Dvorakova E; Chmelarova M; Laco J; Palicka V; Spacek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):298-303. PubMed ID: 23736679
[TBL] [Abstract][Full Text] [Related]
29. Identification of endometrial cancer methylation features using combined methylation analysis methods.
Trimarchi MP; Yan P; Groden J; Bundschuh R; Goodfellow PJ
PLoS One; 2017; 12(3):e0173242. PubMed ID: 28278225
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
Vaskivuo TE; Stenbäck F; Tapanainen JS
Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
[TBL] [Abstract][Full Text] [Related]
32. APC promoter hypermethylation is an early event in endometrial tumorigenesis.
Ignatov A; Bischoff J; Ignatov T; Schwarzenau C; Krebs T; Kuester D; Costa SD; Roessner A; Semczuk A; Schneider-Stock R
Cancer Sci; 2010 Feb; 101(2):321-7. PubMed ID: 19900189
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium.
Li R; Saito T; Tanaka R; Satohisa S; Adachi K; Horie M; Akashi Y; Kudo R
Cancer Lett; 2005 Feb; 219(1):33-40. PubMed ID: 15694662
[TBL] [Abstract][Full Text] [Related]
34. hMLH1 promoter methylation status causes different expression patterns of estrogen receptor protein with endometrial lesion progression.
Nishijima Y; Yoshida T; Nakamura K; Fukuda T
Rinsho Byori; 2013 Feb; 61(2):97-103. PubMed ID: 23672086
[TBL] [Abstract][Full Text] [Related]
35. Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium.
Chmelarova M; Kos S; Dvorakova E; Spacek J; Laco J; Ruszova E; Hrochova K; Palicka V
Clin Chem Lab Med; 2014 Aug; 52(8):1229-34. PubMed ID: 24651021
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia.
Nieminen TT; Gylling A; Abdel-Rahman WM; Nuorva K; Aarnio M; Renkonen-Sinisalo L; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Clin Cancer Res; 2009 Sep; 15(18):5772-83. PubMed ID: 19723644
[TBL] [Abstract][Full Text] [Related]
37. [Pseudogene PTENP1 5'-region methylation in endometrial cancer and hyperplasias].
Kovalenko TF; Sorokina AV; Ozolinia LA; Patrushev LI
Bioorg Khim; 2013; 39(4):445-53. PubMed ID: 24707726
[TBL] [Abstract][Full Text] [Related]
38. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
[TBL] [Abstract][Full Text] [Related]
39. Aberrant Methylation Status of Tumour Suppressor Genes in Ovarian Cancer Tissue and Paired Plasma Samples.
Dvorská D; Braný D; Nagy B; Grendár M; Poka R; Soltész B; Jagelková M; Zelinová K; Lasabová Z; Zubor P; Danková Z
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450846
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
Wang Y; Liu D; Jin X; Song H; Lou G
Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]